Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Life Sciences|January 1, 1990
Purification of L-[3H]nicotine eliminates low affinity bindingE Romm, P M Lippiello, M J Marks, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1991
Characterization of nicotinic receptors on cultured cortical neurons using anti-idiotypic antibodies and ligand bindingP M Lippiello, K G Fernandes, J J Langone, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
The "calcium antagonist" TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester] is a potent, non-competitive, functional antagonist at diverse nicotinic acetylcholine receptor subtypesM Bencherif, C M Eisenhour, R J Prince, et al.
Journal of Neurochemistry|June 15, 2000
The activation and inhibition of human nicotinic acetylcholine receptor by RJR-2403 indicate a selectivity for the alpha4beta2 receptor subtypeR L Papke, J C Webster, P M Lippiello, et al.
Biochemical Pharmacology|August 23, 1996
Modulation of nicotine-evoked [3H]dopamine release from rat striatal synaptosomes by voltage-sensitive calcium channel ligandsR J Prince, K G Fernandes, J C Gregory, et al.
Journal of Neurochemistry|December 1, 1994
Desensitization of nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomesM J Marks, S R Grady, J M Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1996
RJR-2403: a nicotinic agonist with CNS selectivity II. In vivo characterizationP M Lippiello, M Bencherif, J A Gray, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1996
RJR-2403: a nicotinic agonist with CNS selectivity I. In vitro characterizationM Bencherif, M E Lovette, K W Fowler, et al.
Psychopharmacology|April 1, 1996
Relationship between up-regulation of nicotine binding sites in rat brain and delayed cognitive enhancement observed after chronic or acute nicotinic receptor stimulationF A Abdulla, E Bradbury, M R Calaminici, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 13, 1998
The heterocyclic substituted pyridine derivative (+/-)-2-(-3-pyridinyl)-1-azabicyclo[2.2.2]octane (RJR-2429): a selective ligand at nicotinic acetylcholine receptorsM Bencherif, J D Schmitt, B S Bhatti, et al.
Pageof 3